Anika Therapeutics
ANIK
ANIK
158 hedge funds and large institutions have $539M invested in Anika Therapeutics in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 59 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
3% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 59
3% less funds holding
Funds holding: 163 → 158 (-5)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
Holders
158
Holding in Top 10
1
Calls
$1.08M
Puts
$796K
Top Buyers
| 1 | +$16.9M | |
| 2 | +$6.71M | |
| 3 | +$2.73M | |
| 4 |
Bank of New York Mellon
New York
|
+$2.64M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.1M |
Top Sellers
| 1 | -$8.19M | |
| 2 | -$7.32M | |
| 3 | -$4.65M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.55M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$2.4M |